QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~PURSUANT~~Date TOof ~~SECTION 13~~Report ~~OR 15~~(dDate of earliest event reported): August 22, 2018

OFUNIVERSAL ~~THE~~HOSPITAL ~~SECURITIES~~SERVICES, INC. (Exact ~~EXCHANGE~~Name ~~ACT~~of OFRegistrant ~~1934~~as Specified in Charter)

~~Date~~Delaware of(State ~~Report~~or ~~(Date~~Other Jurisdiction of ~~earliest~~Incorporation) ~~event~~000-20086 ~~reported~~(Commission File Number): ~~August 15,~~41-0760940 ~~2018~~(IRS Employer Identification No.)

~~UNIVERSAL~~6625 ~~HOSPITAL~~West ~~SERVICES~~78th Street, Suite ~~INC.~~300 Minneapolis, Minnesota 55439-2604 (Address of Principal Executive Offices) (Zip code)

952-893-3200 (~~Exact Name of~~ Registrant's astelephone ~~Specified~~number, inincluding ~~Charter~~area code)

Delaware		000-20086		41-0760940
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Not Applicable
(Former name or former address, if changed since last report.)

o: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o: Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o: Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o: Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

6625 West 78th Street, Suite 300

Minneapolis, Minnesota 55439-2604

(Address of Principal Executive Offices)

(Zip code)

952-893-3200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

~~Item~~ Item 8.01 Other Events.

As previously announced, UHS Holdco, Inc., a Delaware corporation (“"UHS” Holdco"), the parent company of Universal Hospital Services, Inc., a Delaware corporation (the “"Company”" or "we"), entered into an Agreement and Plan of Merger (the “"Merger Agreement”"), dated August 13, 2018, to effect a business combination between Federal Street Acquisition Corp. (“"FSAC”") and UHS Holdco (the “"Business Combination”"), which will be effected through a number of mergers and a contribution. As a result of the mergers and the contribution, FSAC will become a wholly-owned subsidiary of Agiliti, Inc., a Delaware corporation ~~and~~that is currently a wholly-owned subsidiary of FSAC (“"Agiliti”"), UHS Holdco will become a wholly-owned subsidiary of FSAC, and Agiliti will become a publicly traded company.

~~Furnished~~ On August 22, as2018, ~~Exhibit~~in connection with the Merger Agreement, Agiliti filed a registration statement on Form ~~99.1~~S-4 ~~hereto~~(the "Registration Statement") with the Securities and ~~incorporated~~Exchange byCommission ~~reference~~(the ~~herein~~"SEC") related to the Business Combination. The Company is anfiling this ~~updated~~Form 8-K ~~investor~~to ~~presentation~~update ~~reflecting~~the ~~supplements~~financial and other information included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017 (the "2017 10-K") to reflect the ~~original~~Company's revised financial information and disclosures presented in the Registration Statement. The Company revised the financial information and disclosures included in the 2017 10-K as a result of the Company's previously announced segment reorganization and retrospective adoption of new accounting pronouncements. These changes, which were effective January 1, 2018, impacted the Company's reportable segments and presentation ~~that~~of ~~will~~the beConsolidated ~~used~~Statements byof ~~FSAC~~Operations but did not impact net income (loss). Previously reported segment information has been recast as of August 22, 2018 for all periods presented in ~~connection~~Exhibit 99.1 ~~with~~to reflect the ~~Business~~new ~~Combination~~reporting segment.

~~The information contained in~~ Exhibit 99.1 of isthis ~~being~~Form 8-K ~~furnished~~contains ~~pursuant~~excerpts tofrom ~~Item~~the ~~8.01~~Business description and ~~will~~Management's ~~not~~Discussion beand ~~deemed~~Analysis of Financial Condition and Results of Operations, Report of Independent Registered Accounting Firm, Consolidated Financial Statements and Notes to beConsolidated ~~filed~~Financial Statements and Financial Statement Schedule II—Valuation and Qualifying Accounts. The Consolidated Financial Statements were updated for ~~purposes~~the changes in presentation to the Consolidated Statements of ~~Section 18~~Operations, and certain of the ~~Exchange~~Notes ~~Act,~~to orConsolidated ~~otherwise~~Financial Statements bewere ~~subject~~updated to reflect the ~~liabilities~~recast offinancial ~~that~~information ~~section~~contained therein, ~~nor~~including ~~will~~Notes 1, it2 beand ~~deemed~~16. toExcept beas ~~incorporated~~specifically byset ~~reference~~forth in Exhibit 99.1, the information in the attached exhibit do not reflect any ~~filing~~other ~~under~~events occurring after the ~~Securities~~Company ~~Act~~filed orits 2017 10-K on March 12, 2018. For a discussion of developments subsequent to March 12, 2018, please refer to the ~~Exchange~~reports ~~Act~~and other information that the Company has filed with the SEC, including the Company's reports on Form 10-Q for the periods ended March 31, 2018 and June 30, 2018.

~~Forward~~ The Registration ~~Looking~~Statement ~~Statements~~has not been declared effective by the SEC. This communication shall neither constitute an offer to sell or the solicitation of an offer to buy any securities, which will only be made by Agiliti after the Registration Statement is effective.

~~Certain~~ Forward ~~statements~~Looking ~~made~~Statements herein include forward looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Specifically, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside FSAC’s or UHS’s management’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section entitled “Risk Factors” in the Prospectus filed by FSAC with the SEC and those described in the section entitled “Risk Factors” in UHS’s annual report on Form 10-K for the year ended December 31, 2017 filed with the SEC, as well as UHS’s other filings with the SEC. Important factors, among others, that may affect actual results or outcomes include: the inability to complete the transactions contemplated by the proposed Business Combination; the inability to recognize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, the amount of cash available following any redemptions by FSAC stockholders; the ability to meet NASDAQ’s listing standards following the consummation of the transactions contemplated by the proposed Business Combination; and costs related to the proposed Business Combination. Important factors that could cause the combined company’s actual results or outcomes to differ materially from those discussed in the forward-looking statements include: UHS’s history of net losses; the need for substantial cash to operate and expand the combined company’s business as planned; the combined company’s expected substantial outstanding debt following the business combination; a decrease in the number of patients the combined company’s customers serve; the combined company’s ability to effect change in the manner in which healthcare providers traditionally procure medical equipment; the absence of long-term commitments with customers; the combined company’s ability to renew contracts with group purchasing organizations and integrated delivery networks; changes in reimbursement rates and policies by third-party payors; the impact of healthcare reform initiatives; the impact of significant regulation of the healthcare industry and the need to comply with those regulations; the effect of prolonged negative changes in domestic and global economic conditions; difficulties or delays in the combined company’s continued expansion into certain of UHS’s businesses/geographic markets and developments of new businesses/geographic markets; additional credit risks in increasing business with home care providers and nursing homes, impacts of equipment product recalls or obsolescence; and increases in vendor costs that cannot be passed through to the combined company’s customers.

2 We believe statements in Exhibit 99.1 looking forward in time involve risks and uncertainties. The following factors, among others, could adversely affect our business, operations and financial condition, causing our actual results to differ materially from those expressed in any forward-looking statements:

•: our competitors' activities;
•: our customers' patient census or service needs;
•: global economic conditions' effect on our customers;

~~Neither FSAC nor UHS undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.~~2

•: our ability to maintain existing contracts on contract terms and enter into new contracts with customers;
•: uncertainties as to the effect of non-renewal of existing contracts;
•: consolidation in the health care industry and its effect on prices;
•: our relationships with key suppliers;
•: our ability to change the manner in which health care providers procure medical equipment;;
•: the absence of long-term commitments and cancellations by or disputes with customers;
•: our dependence on key personnel;
•: our ability to identify and manage acquisitions;
•: increases in expenses related to our pension plan;
•: our cash flow fluctuation;
•: the increased credit risks associated with doing business with home care providers and nursing homes;
•: the risk of claims associated with medical equipment we outsource and service;
•: increased costs we cannot pass through;
•: the failure of any management information system;
•: the inherent limitations on internal controls of our financial reporting;
•: the uncertainty surrounding health care reform initiatives;
•: the federal Privacy law risks;
•: the federal Anti-Kickback law risks;
•: changes to third-party payor reimbursement for health care items and services;
•: potential other new health care laws or regulations;
•: our customers operate in a highly regulated environment;
•: our fleet's risk of recalls or obsolescence;
•: our substantial debt service obligations;
•: our need for substantial cash to operate and expand our business as planned;
•: our history of net losses and substantial interest expense; and
•: the risk factors set forth in Item 1A of the 2017 10-K.

~~Item~~ We undertake 9no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.~~01.~~ ~~Financial~~In ~~Statements~~light of these risks, uncertainties and ~~Exhibits~~assumptions, the forward-looking events included in Exhibit 99.1 might not occur

~~(d) Exhibits — See Exhibit Index~~3

~~Exhibit~~ Item ~~Index~~9.01. Financial Statements and Exhibits

(d): Exhibits—See Exhibit Index

Exhibit No.		Description
99.1		Investor Presentation of Federal Street Acquisition Corp. and Universal Hospital Services, Inc., dated August 15, 2018.

Exhibit Index

Exhibit No.			Description

	99.1		Updates, as applicable, to the Business description, Management's Discussion and Analysis of Financial Condition and Results of Operations, Report of Independent Registered Accounting Firm, Consolidated Financial Statements and Notes to Consolidated Financial Statements and Financial Statement Schedule II—Valuation and Qualifying Accounts from the 2017 10-K, as filed with the SEC on March 12, 2018.
	101		The following financial information for the year ended December 31, 2017, formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated Balance Sheets as of December 31, 2017 and 2016, (ii) the Consolidated Statements of Operations for the years ended December 31, 2017, 2016 and 2015, (iii) the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2017, 2016 and 2015, (iv) the Consolidated Statements of Deficit for the years ended December 31, 2017, 2016 and 2015, (v) the Consolidated Statements of Cash Flows for the years ended December 31, 2017, 2016 and 2015, and Notes to Consolidated Financial Statements.

~~SIGNATURES~~4

~~Pursuant~~ to ~~the requirements of the Securities Exchange Act of 1934, Universal Hospital Services, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~ SIGNATURES

	Universal Hospital Services, Inc.
	By:	/s/ James B. Pekarek
		James B. Pekarek
		Executive Vice President and
		Chief Financial Officer
Date: August 15, 2018

Pursuant to the requirements of the Securities Exchange Act of 1934, Universal Hospital Services, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

4Universal Hospital Services, Inc. By: /s/ JAMES B. PEKAREK James B. Pekarek Executive Vice President and Chief Financial Officer

Date: August 22, 2018

QuickLinks

Item 8.01 Other Events.

Item 9.01. Financial Statements and Exhibits

SIGNATURES

Filing Compare · Agiliti Health, Inc.